DocGo Inc. (DCGO)

DocGo's stock price has significantly declined over the past six months, underperforming the S&P500 Index. Key events include a decline in Q3 2025 revenue due to the wind-down of migrant-related programs, an extension of the share repurchase program, and Q4 and full-year 2025 earnings showing revenue decline but raised 2026 guidance. DocGo initiated a strategic alternatives process to maximize shareholder value, and analysts have adjusted price targets lower due to mixed Q4 results.

While specific seasonal patterns are not detailed, DocGo has reported record volumes across major business lines in recent quarters. The virtual care division, SteadyMD, expanded its clinical workforce to meet rising demand for GLP-1 weight loss care. The company also focuses on programs like care gap closure, transitions of care, and vaccination initiatives, which may have varying demand throughout the year.

DocGo, Inc. is a technology-enabled healthcare company providing mobile health and medical transportation services, operating in the Healthcare sector, specifically in the Medical Care Facilities industry. DocGo delivers care directly to patients in homes, workplaces, and community locations through EMTs, paramedics, and licensed clinicians, supported by telehealth. The company operates through Mobile Health Services and Transportation Services (Ambulnz). Mobile Health Services include mobile urgent care, exams, vaccinations, monitoring, and event services. Transportation Services (Ambulnz) provides emergency and non-emergency transport. DocGo also offers virtual care through SteadyMD, including remote patient monitoring and telehealth. The company leverages AI-powered technology and a dedicated field staff to enhance patient care and drive business efficiencies, serving municipalities, hospital systems, health insurers, and businesses.

DocGo operates across the United States and the United Kingdom. In the U.S., it provides mobile health or medical transportation services in over 30 states, with virtual care services available in all 50 states through SteadyMD.

DocGo was named one of Ethisphere's 2026 World's Most Ethical Companies, highlighting its commitment to business integrity through ethics, compliance, and governance programs. However, the decline in revenue due to the wind-down of migrant health programs has presented operational and financial challenges, potentially impacting public perception.

DocGo's stock ownership includes institutional, insider, and retail investors. Institutions hold approximately 42.20% to 56.44% of the stock, with major holders including BlackRock and Vanguard Group. Insiders own approximately 7.00% to 26.53%, with Stanley Vashovsky being the largest individual shareholder. Retail investors hold approximately 31.27% to 63.04% of the stock.